HPV Testing and PAP Test Market Size Report 2022-2027: Global Industry Share, Trends, Growth and Forecast

The latest research study "HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global HPV testing and PAP test market size reached US$ 3.73 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 5.37 Billion by 2027 exhibiting a CAGR of 6.10% during 2022-2027.

Covid-19 Impact:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Download free sample brochure: https://www.imarcgroup.com/hpv-testing-pap-test-market/requestsample

Industry Definition and Application:

Human papillomavirus (HPV) refers to a sexually transmitted infection (STI) that causes cancer of the oropharynx, cervix, anus. It is detected with several tests and procedures, such as HPV and Papanicolaou (PAP) tests which include microscopic observation of specimens and head, cervical, and neck cancer screening. These tests are conducted to analyze the presence of human papillomavirus, which develops genital warts, and determine changes in the cell and the presence of abnormal cells in the cervix. As a result, HPV and PAP tests are extensively adopted by doctors and gynecologists in hospitals and clinics.

HPV Testing and PAP Test Market Trends and Drivers:

The increasing prevalence of cervical cancer amongst the masses due to the presence of papillomavirus is escalating the demand for novel, technologically advanced, and cost-effective HPV and PAP screening tests. In addition, the introduction of machine-assisted, plasma, and cell-free deoxyribonucleic acid (DNA) screenings and handheld devices that rely on artificial intelligence (AI) to detect HPV represents another major growth-inducing factor.

Moreover, with the sudden outbreak of the coronavirus disease (COVID-19) pandemic, e several key players are conducting ongoing clinical trials and research and development (R&D) activities to introduce easy-to-use home HPV screening tests.

Along with this, the expanding healthcare sector and various favorable initiatives undertaken by government authorities and non-governmental organizations (NGOs) to inform people about the causes of cervical cancer and the benefits of having HPV and PAP tests are propelling market growth.

Click here to view detailed information with table of content: https://www.imarcgroup.com/hpv-testing-pap-test-market

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Test Type:
• HPV Test
• Pap Test
• Co-testing

Breakup by Product:
• Instruments
• Consumables
• Services

Breakup by Application:
• Cervical Cancer Screening
• Vaginal Cancer Screening

Breakup by End User:
• Hospitals and Clinics
• Laboratories
• Diagnostic Centers
• Others

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

List of Major Key Players:

The major players in the market are Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.

Also, Read Latest Research Reports by IMARC Group:

Controlled Release Fertilizer Market Report: https://www.imarcgroup.com/controlled-release-fertilizer-market

OLED Materials Market Trends: https://www.imarcgroup.com/oled-materials-market

Fluorochemicals Market Forecast: https://www.imarcgroup.com/fluorochemicals-market

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.